{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:51:54Z","timestamp":1789667514709,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.bpobgyn.2011.12.007","type":"journal-article","created":{"date-parts":[[2012,1,29]],"date-time":"2012-01-29T23:57:16Z","timestamp":1327881436000},"page":"311-324","source":"Crossref","is-referenced-by-count":54,"title":["Endometrial cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"Vivek","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2011.12.007_bib1","unstructured":"Fast Stats: An interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute. http:\/\/seer.cancer.gov\/faststats. [accessed on 12.12.2011]."},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00000421-200010000-00009","article-title":"Characteristics and outcome of endometrial carcinoma patients age 45 years and younger","volume":"23","author":"Tran","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.AOG.0000154151.14516.f7","article-title":"Risk factors for young premenopausal women with endometrial cancer","volume":"105","author":"Soliman","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12094-008-0206-9","article-title":"Gynecologic cancers associated with Lynch syndrome\/HNPCC","volume":"10","author":"Schmeler","year":"2008","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/GRF.0b013e318218607c","article-title":"Management of endometrial cancer in young women","volume":"54","author":"Shah","year":"2011","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1586\/14737140.6.1.27","article-title":"Fertility-sparing therapy for young women with endometrial cancer","volume":"6","author":"Frumovitz","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ygyno.2009.05.038","article-title":"Young patients with endometrial cancer: How many could be eligible for fertility-sparing treatment?","volume":"114","author":"Navarria","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib8","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/humrep\/dem088","article-title":"Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer","volume":"22","author":"Yamazawa","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ygyno.2006.11.013","article-title":"Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review","volume":"104","author":"Shamshirsaz","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.AOG.0000172423.64995.6f","article-title":"Coexisting ovarian malignancy in young women with endometrial cancer","volume":"106","author":"Walsh","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/gyno.2001.6400","article-title":"Simultaneously detected endometrial and ovarian carcinomas: a prospective clinicopathologic study of 74 cases: a Gynecologic Oncology Group Study","volume":"83","author":"Zaino","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0029-7844(97)00668-6","article-title":"Profile of women 45 years of age and younger with endometrial cancer","volume":"91","author":"Evans-Metcalf","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/annonc\/mdq463","article-title":"Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women","volume":"22","author":"Minig","year":"2011","journal-title":"Ann Oncol"},{"issue":"8 Suppl.","key":"10.1016\/j.bpobgyn.2011.12.007_bib14","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1525-1438.2007.00996.x","article-title":"The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology","volume":"18","author":"Chi","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0090-8258(85)90211-2","article-title":"Endometrial carcinoma in premenopausal women: a clinicopathological study","volume":"20","author":"Quinn","year":"1985","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1525-1438.2000.010003212.x","article-title":"Prognostic factors in young women with endometrial carcinoma: a report of 20 cases and review of literature","volume":"10","author":"Yamazawa","year":"2000","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/oxfordjournals.jjco.a023199","article-title":"Comparison of the clinicopathological characteristics of premenopausal and postmenopausal endometrial carcinomas: analysis of endocrinologically evaluated cases","volume":"26","author":"Yasumizu","year":"1996","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.AOG.0000255980.88205.15","article-title":"Prognostic factors for uterine cancer in reproductive-aged women","volume":"109","author":"Lee","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ygyno.2008.12.017","article-title":"Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma","volume":"113","author":"Leitao","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0029-7844(95)00105-Z","article-title":"Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer","volume":"86","author":"Larson","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00004347-199801000-00007","article-title":"Interinstitutional surgical pathology review in gynecologic oncology: I. Cancer in endometrial curettings and biopsies","volume":"17","author":"Jacques","year":"1998","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00004347-199801000-00008","article-title":"Interinstitutional surgical pathology review in gynecologic oncology: II. Endometrial cancer in hysterectomy specimens","volume":"17","author":"Jacques","year":"1998","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tem.2011.01.005","article-title":"Progesterone: the ultimate endometrial tumor suppressor","volume":"22","author":"Yang","year":"2011","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.gco.0000192994.37965.c6","article-title":"The role of hormones for the treatment of endometrial hyperplasia and endometrial cancer","volume":"18","author":"Lai","year":"2006","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib26","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.fertnstert.2008.12.009","article-title":"Conservative surgical management of stage IA endometrial carcinoma for fertility preservation","volume":"93","author":"Mazzon","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ygyno.2011.03.017","article-title":"Prognostic significance of DNA ploidy in stage I endometrial cancer","volume":"122","author":"Song","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/09513590902733733","article-title":"The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option","volume":"25","author":"Gadducci","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib29","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/uog.5295","article-title":"Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging","volume":"31","author":"Savelli","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/gyno.2000.5820","article-title":"Inability of preoperative computed tomography scans to accurately predict the extent of myometrial invasion and extracorporal spread in endometrial cancer","volume":"78","author":"Zerbe","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6874-8-8","article-title":"A systematic review of tests for lymph node status in primary endometrial cancer","volume":"8","author":"Selman","year":"2008","journal-title":"BMC Women's Health"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejrad.2010.01.026","article-title":"The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis","volume":"76","author":"Sala","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib33","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/IGC.0b013e3181e9509f","article-title":"Predictive value of magnetic resonance imaging in assessing myometrial invasion in endometrial cancer","volume":"20","author":"Cade","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/IGC.0b013e3181995fd9","article-title":"Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma","volume":"19","author":"Sala","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/01443610601056418","article-title":"Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: comparison of magnetic resonance imaging and histopathologic evaluation","volume":"27","author":"Vasconcelos","year":"2007","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib36","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/GRF.0b013e3181f97d02","article-title":"Fertility-preserving surgical procedures for patients with gynecologic malignancies","volume":"53","author":"Rasool","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib37","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1200\/JCO.2005.07.166","article-title":"Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer","volume":"23","author":"Rockall","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib38","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2004.08.009","article-title":"Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer","volume":"95","author":"Horowitz","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1447-0756.2008.00832.x","article-title":"Positron emission tomography with the glucose analog [18F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: Comparison with CT and MRI findings","volume":"35","author":"Inubashiri","year":"2009","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<111::AID-CNCR15>3.0.CO;2-#","article-title":"Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis","volume":"83","author":"Saegusa","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0029-7844(97)00297-4","article-title":"Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40","volume":"90","author":"Randall","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib42","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/IGC.0b013e3181aae1fb","article-title":"Conservative Treatment With Progestin and Pregnancy Outcomes in Endometrial Cancer","volume":"19","author":"Hahn","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl.","key":"10.1016\/j.bpobgyn.2011.12.007_bib43","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ygyno.2008.07.056","article-title":"Sparing fertility in young patients with endometrial cancer","volume":"111","author":"Chiva","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib44","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1471-0528.2010.02552.x","article-title":"Progestogen treatment options for early endometrial cancer","volume":"117","author":"Cade","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ygyno.2004.06.045","article-title":"Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review","volume":"95","author":"Ramirez","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib46","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mob.2002.122130","article-title":"Intrauterine progesterone treatment of early endometrial cancer","volume":"186","author":"Montz","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib48","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/PAS.0b013e31802d68ce","article-title":"Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins","volume":"31","author":"Wheeler","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib49","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/IGC.0b013e3181e94f5a","article-title":"Fertility-sparing therapy in young women with endometrial cancer","volume":"20","author":"Erkanli","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib50","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1471-0528.2010.02552.x","article-title":"Progestogen treatment options for endometrial cancer","volume":"117","author":"Cade","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib51","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/AOG.0b013e3181b190d5","article-title":"Complex atypical endometrial hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage","volume":"114","author":"Suh-Burgmann","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib52","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2008.06.014","article-title":"Treatment results of endometrial hyperplasia after prospective D-score classification","volume":"111","author":"\u00d8rbo","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2011.12.007_bib53","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1525-1438.2006.00219.x","article-title":"Successful pregnancy after hysteroscopic removal of grade I endometrial carcinoma in a young woman with Lynch syndrome","volume":"16","author":"Sparac","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib54","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ijc.10667","article-title":"Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer","volume":"102","author":"Boks","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib55","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2011.06.005","article-title":"Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40 years of age or younger","volume":"123","author":"Shih","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib56","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000209324","article-title":"Fertility-Sparing in Endometrial Cancer","volume":"67","author":"Tangjitgamol","year":"2009","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.bpobgyn.2011.12.007_bib57","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ygyno.2003.08.007","article-title":"Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and\/or complex hyperplasia with atypia","volume":"91","author":"Lowe","year":"2003","journal-title":"Gynecol Oncol"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693412000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693412000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T05:41:39Z","timestamp":1640583699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693412000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1521693412000247"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.12.007","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}